Financial Daily from THE HINDU group of publications
Thursday, Jan 29, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals


Sun Pharma Q3 net rises

MUMBAI: Sun Pharmaceuticals Industries Ltd has clocked a net profit of Rs 70.4 crore for the quarter ended December 31, 2003, compared with Rs 55.8 crore in the corresponding period of the previous year. Total income increased to Rs 281 crore from Rs 221 crore previously.

Meanwhile, the company told BSE that its board of directors had accepted the resignation of Mr Narendra N. Borkar, Director of the company, with effect from January 15.

The board also appointed Mr Ashwin Dani as an additional independent non-executive director of the company with immediate effect.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Nirma sales higher


Sterlite Ind Q3 net up 43.19 pc
Kesoram Ind Q3 net up at Rs 10.5 cr
Satnam Overseas net profit up 60 pc
ITC Hotels total income soars
Matrix Labs Q3 sales rise 80 pc; to pay 50 pc interim
Merck Q4 net at Rs 20 crore
Sun Pharma Q3 net rises
Nicholas Piramal posts 76 pc growth in third quarter net
Raymond net jumps 60 pc on better operations
Bombay Dyeing profit at Rs 13 cr
Apollo Tyres net down on high natural rubber prices
MRF turnover up, net down in Q1
11 pc rise in Dabur turnover in Q3
Elgi Equipments gross sales up 46 pc
Blue Star Q3 net at Rs 3.81 cr
Agro Tech Q3 net rises five-fold
HCL Info Q2 net at Rs 41 cr, to pay 50% interim
CMC revenues jump 46 pc
Heritage Foods Q3 sales up
LIC Housing net up at Rs 45 cr; to hike equity
Regency Ceramics sales, net up
Asian Paints net slips 5 pc
Credit offtake lifts IOB net 57 pc
Andhra Bank net falls on lower trading income
Dena Bank Q3 net up at Rs 71.85 cr



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line